Literature DB >> 6810489

Tocainide-associated interstitial pneumonitis.

A C Braude, E Downar, D W Chamberlain, A S Rebuck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810489      PMCID: PMC459304          DOI: 10.1136/thx.37.4.309

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity.

Authors:  T A Hutchinson; J M Leventhal; M S Kramer; F E Karch; A G Lipman; A R Feinstein
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

2.  A prospective randomized trial of tocainide in patients following myocardial infarction.

Authors:  B C Bastian; P W Macfarlane; J H McLauchlan; D Ballantyne; P Clark; W S Hillis; A P Rae; I Hutton
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

3.  Tocainide-associated interstitial pneumonitis.

Authors:  G M Perlow; B P Jain; S G Pauker; H S Zarren; D C Wistran; R L Epstein
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

Review 4.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

5.  Safety evaluation of tocainide in the American Emergency Use Program.

Authors:  H R Horn; Z Hadidian; J L Johnson; H G Vassallo; J H Williams; M D Young
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

  5 in total
  2 in total

1.  Irreversible interstitial pneumonitis associated with tocainide therapy.

Authors:  B Van Natta; M Lazarus; C Li
Journal:  West J Med       Date:  1988-07

Review 2.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.